Propranolol & Migraines

Propranolol (brand name Inderal) is a beta-blocker, a type of medication originally developed for heart conditions and high blood pressure. It has been used for migraine prevention since the 1960s and remains one of the most prescribed preventive medications today.

Beta-blockers work by blocking the effects of adrenaline (epinephrine) on beta-adrenergic receptors. For migraines, propranolol appears to stabilize blood vessel tone, reduce the brain's sensitivity to migraine triggers, and modulate serotonin activity. It also has a calming effect on the nervous system, which may explain why it helps people whose migraines are strongly linked to stress or anxiety.

Propranolol for migraines is typically started at 40 mg per day, split into two doses or taken once daily with the extended-release form. The dose is gradually increased based on response and tolerability, with most people finding their effective dose between 80-240 mg per day.

Consistency is key with propranolol. It should be taken at the same time each day, and you should not skip doses. Missing doses can cause rebound effects. Like most preventive medications, propranolol may take four to six weeks to show its full benefit. Your doctor will monitor your blood pressure and heart rate during dose adjustments.

Because propranolol slows the heart rate and lowers blood pressure, the most common side effects are fatigue, cold hands and feet, dizziness, and sleep disturbances (including vivid dreams). Some people experience exercise intolerance because their heart rate can't increase normally during physical activity.

Propranolol is not appropriate for people with asthma, as it can worsen breathing problems. People with diabetes should use it cautiously because it can mask the symptoms of low blood sugar. It should not be stopped abruptly, as sudden discontinuation can cause rebound high blood pressure or increased heart rate. Important interaction to note: if you also take rizatriptan, the triptan dose should be reduced to 5 mg.

Propranolol has decades of research behind it. Clinical trials consistently show it reduces migraine frequency by 40-50% in responsive patients. It's considered a first-line preventive medication by major headache societies worldwide and has one of the strongest evidence bases among migraine preventives.

Studies have also explored propranolol in combination with other treatments. It can be used alongside topiramate or newer CGRP-based therapies when a single medication isn't sufficient. Propranolol also has particular value for people who experience migraines triggered by anxiety or performance-related stress, thanks to its anxiety-reducing properties.

When you start propranolol, your baseline migraine frequency is the benchmark everything gets measured against. If you haven't been tracking attacks before starting, it's hard to know whether the medication is truly making a difference or if you're just having a good month.

CalmGrid makes this comparison straightforward. By logging every migraine before and after starting propranolol, you get a clear picture of whether your attack frequency, severity, and duration are trending downward. This data is essential for your doctor when deciding whether to continue, adjust the dose, or consider alternative treatments.